Streetbeat News

Products Services

DOGEUSD

Dogecoin (DOGE) has rebounded to $0.10, showing a 15% increase from its recent bottom. Analysts are optimistic about further gains if DOGE breaks the $0.10 mark, with a key resistance level at $0.143. Despite market downturns, DOGE has shown resilience by closing above the 200-day SMA. However, challenges remain, and a confirmed bullish trend is yet to be seen.

Portfolio Pulse from Khyathi Dalal

August 07, 2024 | 12:12 pm

CM

CIBC has announced a strategic collaboration with Creative Destruction Lab to empower companies through AI innovation. This partnership aims to leverage AI to drive growth and innovation for businesses.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 12:10 pm

SNOW

TRU

TransUnion has partnered with Snowflake to launch TruIQ Data Enrichment on the Snowflake Marketplace. This collaboration provides joint customers with on-demand access to pseudonymized TransUnion credit data.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 12:09 pm

MDT

Medtronic has received FDA approval for its new Simplera product, which is expected to enhance its market position in the medical device industry.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 12:06 pm

NAII

Natural Alternatives International (NAII) has launched TriBsyn, a new carnosine booster that uses CarnoSyn® Beta-Alanine and patent-pending technology to improve bioavailability and absorption, while eliminating paresthesia.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 12:03 pm

EYEN

Formosa Pharmaceuticals has signed a non-binding terms agreement with Eyenovia to co-develop Clobetasol Propionate Ophthalmic Suspension for the relief of dry eye disease.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 12:01 pm

ZVSA

ZyVersa Therapeutics has announced the publication of data in a peer-reviewed journal demonstrating that extracellular ASC plays a crucial role in the aggregation and deposition of amyloid A fibrils, which are linked to chronic inflammatory conditions.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 11:56 am

REKR

Rekor Systems announced the initial adoption of its Rekor Command platform by Departments of Transportation in Oklahoma, Kansas, and Umatilla County, Oregon.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 11:41 am

NGNE

Neurogene's NGN-401 has received Regenerative Medicine Advanced Therapy (RMAT) designation from the FDA for the treatment of Rett Syndrome. This designation is expected to expedite the development and review process of NGN-401, potentially bringing a new treatment option to market faster.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 11:36 am

NWL

Newell Brands (NASDAQ:NWL), the maker of Sharpie pens, is shifting some of its production out of China to reduce tariff uncertainties. The company will relocate its writing business manufacturing to Tennessee and move kitchen appliance manufacturing to Vietnam, Thailand, Indonesia, and other locations. This strategic move aims to reduce Newell's dependence on China, automate U.S. manufacturing, and save on time and fluctuating freight costs.

Portfolio Pulse from Benzinga Neuro

August 07, 2024 | 11:34 am